Articles

New U.S. Food and Drug Administration (FDA) indications for two key heart failure device therapies may help improve survival, slow the progress of the disease and, in some cases, reverse its...

There were many unique technologies showcased at the recent American College of Cardiology (ACC) 2010 Scientific Sessions, which may impact the practice of cardiology in the near future.

...

As intravascular ultrasound (IVUS) becomes a more common tool in cath labs to assess lesions and stent treatments, new innovations loom on the horizon. These tools include forward-looking IVUS and...

Intracardiac echocardiography (ICE) offers a clearer view of transcatheter devices and electrophysiology (EP) procedures from inside the heart.

Several paclitaxel drug-eluting balloons (DEBs) are currently available on the European market, and several others are in development. There are currently no DEBs available in the United States....

Drug-eluting balloons (DEBs) may offer new options in treating peripheral vessels and restenosis. DEBs already offer an alternative treatment tool in Europe, and the first DEB clinical trial in...

In recent years, many medical device companies saw the underserved lower extremity as an opportunity to enter the market for peripheral artery disease (PAD) treatments. For this reason, device...

March 26, 2010 – When actor John Ritter died suddenly in 2003 from a tear in his thoracic aorta, the tragedy brought attention to a rare but deadly condition that takes the lives of an estimated...

March 17, 2010 – New Results from PLATO trial suggest ticagrelor (Brilinta) leads to lower mortality and no increased risk of bleeding when compared to clopidogrel (Plavix) in patients with acute...

March 17, 2010 – Body size, gender and the complexity of heart disease significantly influence how much cumulative radiation skin dose patients receive during percutaneous coronary intervention (...